Controversies in the management of testicular seminoma

Seminars in Urologic Oncology

Volumn 20, Issue 4, 2002, Pages 227-233

  Fleshner, Neil ^a,b   Warde, Padraig ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Division of Urology   (Canada)

Author keywords

Chemotherapy; Controversies; Seminoma; Surveillance

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN;

ADVANCED CANCER; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; LYMPHADENECTOMY; MALE; NEUTROPENIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REPRODUCTIVE TOXICITY; REVIEW; SEMINOMA; SIDE EFFECT; TREATMENT FAILURE; TREATMENT INDICATION;

HUMANS; LYMPH NODE EXCISION; MALE; MONITORING, PHYSIOLOGIC; SEMINOMA; SOCIOECONOMIC FACTORS; TESTICULAR NEOPLASMS;

EID: 0036864080     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: 10.1053/suro.2002.36979     Document Type: Review

References (49)

1. Foster RS: Early stage testis cancer. Curr Treat Options Oncol 2:413-419, 2001
2. Power DA, Brown RS, Brock CS, et al: Trends in testicular carcinoma in England and Wales, 1971-99 BJU Int 87:361-365, 2001
3. Weir HK, Marrett LD, Moravan V: Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996. CMAJ 160:201-205, 1999
4. Steele GS, Richie JP, Stewart AK, et al: The National Cancer Data Base report on patterns of care for lesticular carcinoma, 1986-1996. Cancer 86:2171-2183, 1999
5. Dosmann MA, Zagars GK: Post-orchiectomy radiotherapy for stages I and II testicular seminoma. Int J Radiat Oncol Biol Phys 26:381-390, 1993
6. Fossa SD, Aass N, Kaalhus O: Radiotherapy for testicular seminoma stage l: Treatment results and long term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 16:383-388, 1989
7. Giacchetti S, Raoul Y, Wibault P et al: Treatment of stage I testis seminoma by radiotherapy: Long-term results - A 30-year experience. Int J Radiat Oncol Biol Phys 27:3-9, 1993
8. Warde P, Gospodarowicz MK, Panzarella T, et al: Stage I testicular seminoma: Results of adjuvant radiation and surveillance. J Clin Oncol 13:2255-2262, 1995
9. Willan BID, McGowan DG: Seminoma of the testis: A 22-year experience with radiotherapy. Int J Radiat Oncol Biol Phys 11:1769-1775, 1985
10. Oliver RT, Edmonds PM, Ong JT, et al: Pilot studies of 2 and I course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial? Int J Radiat Oncol Biol Phys 19:3-8, 1994
11. Ramakrishnan S, Champion AE, Dorreen MS, et al: Stage I seminoma of the testis: Is post-orchidectomy surveillance a safe alternative to routine postoperative radiotherapy? Clin Oncol 4:284-286, 1992
12. Horwich A, Alsanjari N, Ahern R, et al: Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 65:775-778, 1992
13. Von der Maase H, Specht L, Jacobsen A, et al: Surveillance following orchiectomy for stage I seminoma of the testis. Eur J Cancer 29:1931-1934, 1993
14. Warde P, Jewett MA: Surveillance for stage I testicular seminoma. Is it a good option. Urol Clin North Am 16:290-294, 1998
15. Michael H, Lucia J, Foster RS, et al: The pathology of late recurrences of testicular germ cell tumors. Am J Surg Pathol 24:257-273, 2000
16. Warde P, Gospodarowicz M, Banerjee D, et al: Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol 157:1705-1709, 1997
17. Senturia YD, Peckham CS, Peckham MJ: Children lathered by men treated for testicular cancer. Lancet 2:766-769, 1985
18. Ohyama C, Kyan A, Satoh M, et al: Bilateral testicular tumors: A report of nine cases with long term follow-up. Int J Urol 9:173-177, 2002
19. Moller H, Mellemgaard A, Jacobsen GK, et al: Incidence of second primary cancer following testicular cancer. Eur J Cancer 29:673-676, 1993
20. van Leenwen FE, Stigglebout AM, van den Belt-Dusebout AW, et al: Second cancer risk following testicular cancer. J Clin Oncol 11:415-424, 1993
21. Travis LB, Curtis RE, Hankey RE: Second malignancies after testicular cancer (letter). J Clin Oncol 13:533-534, 1995
22. Travis LB, Curtis RE, Storm H, et al: Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Nalt Cancer Inst 89:1429-1439, 1997
23. Ruther U, Dieckmann K, Bussar-Maatz R, et al: Second malignancies following pure seminoma. Oncology 58:75-82, 2000
24. Caffo O, Amichetti M, Tomio L, et al: Quality of life after radiotherapy for early-stage testicular seminoma Radiother Oncol 59:13-20, 2001
25. Tinkler SD, Howard GC, Kerr GR: Sexual morbidity following radiotherapy for germ cell tumors of the testis. Radiother Oncol 25:207-212, 1992
26. Hao D, Seidel J, Brant R, et al: Compliance of clinical stage I non seminomatous germ cell tumor patients with surveillance. J Urol 160:768-771, 1998
27. Warde P, Gospodarowicz M, Panzarella T, et al: Issues in the management of stage I testicular seminoma. Int J Radiat Oncol Biol Phys 39:156-159, 1997
28. Sharda NN, Kinsella TJ, Ritter MA: Adjuvant radiation vs observation: A cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 14:2993-2999, 1996
29. Oliver RT, Edmonds PM, Ong JY, et al: Pilot studies of 2 or 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 29:308, 1994
30. Dieckmann KP, Krain J, Kuster J, et al: Adjuvant carboplatin treatment for seminoma clinical stage I. J Cancer Res Clin Oncol 122:63-66, 1996
31. Steiner H, Hold L, Wirtenbuger W, et al: Long-term experience with carboplatin monotherapy for clinical stage I seminoma: A retrospective single-center study. Urology 60:324-328, 2002
32. Reiter WJ, Brodowicz T, Alavi S, et al: Twelve-year experience with 2 courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma. J Clin Oncol 19:101-104, 2001
33. Fiveash J, Sandler HM: Controversies in the management of stage I seminoma. Oncology 12:1203-1213, 1998
34. Dieckmann KP, Bruggeboes B, Pilchmeier U, et al: Adjuvant treatment of clinical stage I seminoma: Is a single course of carboplatin sufficient? Urology 55:102-106, 2000
35. Strumberg D, Brugge S, Kom MW, et al: Evaluation of long-term toxicity in patients after cis-platinum based chemotherapy for non-seminomatous testicular cancer. Ann Oncol 13: 229-236, 2002
36. Snowden JA, Laidlaw ST, Champion AE, et al: Acute promyelocytic leukemia after treatment for seminoma with carboplatin. Lancet 344:1361, 1994
37. Bajorin DF, Herr H, Motzer RJ, et al: Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors. Semin Oncol 19:148-158, 1992
38. Warren GP, Einhorn LH: Gallium scans in the evaluation of residual masses after chemotherapy for seminoma. J Clin Oncol 13:2784-2788, 1995
39. Maszek P, Lumbroso J, Theodore C, et al: Fluorodeoxyglucose (FDO) positron emission tomography (PET) in testicular germ cell tumors in adults: Preliminary French clinical evaluation, development of the technique and its clinical applications. Prog Urol 10:1190-1199, 2000
40. Herr HW, Sheinfeld J, Puc HS, et al: Surgery for post chemotherapy residual mass in serninoma. J Urol 157:860-862, 1997
41. Puc HS, Heelan R, Mazumdar M, et al: Management of residual mass in advanced seminoma: Results and recommendations from the Memorial Sloan Kettering Cancer Center. J Clin Oncol 14:454-460, 1996
42. Ravi R, Ong J, Oliver RT, et al: The management of residual masses after chemotherapy in metastatic seminoma, BJU Int 83:649-653, 1999
43. Schultz SM, Einhom LH, Conces DJ, et al: Management of postchemotherapy residual glass in patients with advanced seminoma: Indiana University experience. J Clin Oncol 7:1497-1503, 1989
44. Horwich A, Paluchowska B, Norman A, et al: Residual mass following chemotherapy for seminoma. Ann Oncol 8:37-40, 1997
45. Duschesne GM, Stenning SP, Aass N, et al: Radiotherapy after chemotherapy for metastatic seminoma - A diminishing role. Eur J Cancer 33:829-835, 1997
46. Warde P, Gospodarowicz M, Panzarella T, et al: Management of stage II seminoma. J Clin Oncol 16:290-294, 1998
47. Dosman MA, Zagars GK: Post-orchidectomy radiotherapy for stages I and II testicular seminoma. Int J Radiat Oncol Biol Phys 26:545-546, 1993
48. Fossa SD, Horwich A: Current status of chemotherapy in advanced seminoms. Eur J Cancer 33:181-183, 1997
49. Zagars GK, Pollack A: Radiotherapy for stage II testicular seminoma. Int J Radial Oncol Biol Phys 51:643-649, 2001